If you made any changes in Pure, your changes will be visible here soon.

Research Output 1982 2019

Filter
Chapter
2014

Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells

Rexer, B. N., Chanthaphaychith, S., Dahlman, K. B. & Arteaga, C. L., Jan 1 2014, Cancer Cell Signaling: Targeting Signaling Pathways Toward Therapeutic Approaches to Cancer. Apple Academic Press, p. 55-80 26 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

1-Phosphatidylinositol 4-Kinase
Phosphatidylinositols
Phosphotransferases
Cells
Breast Neoplasms

Newer targeted therapy

Mayer, I. A. & Arteaga, C. L., May 14 2014, Diseases of the Breast: Fifth Edition. Wolters Kluwer Health Adis (ESP)

Research output: Chapter in Book/Report/Conference proceedingChapter

Therapeutics
2003

ErbB-targeted therapeutic approaches in human cancer

Arteaga, C. L., Dec 19 2003, The EGF Receptor Family: Biologic Mechanisms and Role in Cancer. Elsevier Inc., p. 127-135 9 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ligands
Antibodies, Monoclonal, Humanized
Neoplasms
Endocytosis
Epidermal Growth Factor Receptor